This wildly popular drug is a synthetic form of GLP-1 (glucagon-like peptide-1), a hormone that regulates blood sugar and curbs appetite
Eduard Vieta has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, AbbVie, Adamed, Alcediag, Angelini, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Casen-Recordati, Celon Pharma, Clariane, Compass, Dainippon Sumitomo Pharma, Esteve, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Intra-Cellular therapies, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Mitsubishi Tanabe Pharma, Newraxpharm, Newron, Novartis, Organon, Orion Corporation, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris, outside the submitted work
administration of Ang IV, Ang II and the dopamine receptor agonist fenoldopam showed a high correlation between RBF and CBF measurements, excluding the above possibility
Pure Peptides UK supports the dissemination of this research-focused information for UK laboratories and educational institutions